Coexistence of Vitiligo and Hyperpigmentation: A Quiz

Authors

  • Laure Lemarcq SKIN Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium; Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium https://orcid.org/0000-0002-6241-5194
  • Maarten De Vis Department of Endocrinology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium https://orcid.org/0000-0002-5457-0645
  • Sophie Deweer Department of Endocrinology and Diabetology, Algemeen Ziekenhuis Sint-Elisabeth Zottegem, Belgium
  • Jan Gutermuth SKIN Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium; Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
  • Brigitte Velkeniers Department of Internal Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium https://orcid.org/0000-0001-8577-9698

DOI:

https://doi.org/10.2340/actadv.v104.35429

Keywords:

Cushing’s disease, rebound autoimmunity, vitiligo, Nelson’s syndrome, hyperpigmentation, adrenocorticotropic hormone

Abstract

Abstract is missing (Quiz)

Downloads

Download data is not yet available.

References

Nelson DH, Meakin JW, Dealy JB Jr, Matson DD, Emerson K Jr, Thorn GW. ACTH-producing tumor of the pituitary gland. N Engl J Med 1958; 259: 161-164.

https://doi.org/10.1056/NEJM195807242590403 DOI: https://doi.org/10.1056/NEJM195807242590403

Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of Cushing's syndrome: state of the art. Lancet Diabetes Endocrinol 2016; 4: 611-629.

https://doi.org/10.1016/S2213-8587(16)00086-3 DOI: https://doi.org/10.1016/S2213-8587(16)00086-3

da Mota F, Murray C, Ezzat S. Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature. J Clin Endocrinol Metab 2011; 96: E1670-1674.

https://doi.org/10.1210/jc.2011-1317 DOI: https://doi.org/10.1210/jc.2011-1317

Fountas A, Karavitaki N. Nelson's syndrome: an update. Endocrinol Metab Clin North Am 2020; 49: 413-432.

https://doi.org/10.1016/j.ecl.2020.05.004 DOI: https://doi.org/10.1016/j.ecl.2020.05.004

Patel J, Eloy JA, Liu JK. Nelson's syndrome: a review of the clinical manifestations, pathophysiology, and treatment strategies. Neurosurg Focus 2015; 38: E14.

https://doi.org/10.3171/2014.10.FOCUS14681 DOI: https://doi.org/10.3171/2014.10.FOCUS14681

Barber TM, Adams E, Ansorge O, Byrne JV, Karavitaki N, Wass JA. Nelson's syndrome. Eur J Endocrinol 2010; 163: 495-507.

https://doi.org/10.1530/EJE-10-0466 DOI: https://doi.org/10.1530/EJE-10-0466

Herraiz C, Martínez-Vicente I, Maresca V. The α-melanocyte-stimulating hormone/melanocortin-1 receptor interaction: a driver of pleiotropic effects beyond pigmentation. Pigment Cell Melanoma Res 2021; 34: 748-761.

https://doi.org/10.1111/pcmr.12980 DOI: https://doi.org/10.1111/pcmr.12980

Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004; 84: 1155-1228.

https://doi.org/10.1152/physrev.00044.2003 DOI: https://doi.org/10.1152/physrev.00044.2003

Published

2024-02-21

How to Cite

Lemarcq, L., De Vis, M., Deweer, S., Gutermuth, J., & Velkeniers, B. (2024). Coexistence of Vitiligo and Hyperpigmentation: A Quiz. Acta Dermato-Venereologica, 104, adv35429. https://doi.org/10.2340/actadv.v104.35429